Form 4: Mira Pharmaceuticals Director Denil Nanji Shekhat Receives Stock Options
SEC Form 4
Director Denil Nanji Shekhat of Mira Pharmaceuticals, Inc. receives stock options as part of a consulting agreement.
Summary
- Denil Nanji Shekhat, a director of MIRA Pharmaceuticals, Inc., received stock options on June 18, 2024.
- The options were granted under the company's 2022 Omnibus Incentive Plan and a consulting agreement.
- Shekhat received 50,000 nonqualified stock options with an exercise price of $0.71 per share.
- These options vest in three equal tranches: the first immediately on June 18, 2024, the second on December 18, 2024, and the final on June 18, 2025.
- Shekhat also disposed of 41,666 stock options.
- After the transaction, Shekhat still holds derivative securities.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of stock option grants, which is generally neutral. The grant itself can be seen as a positive sign of incentivizing management, but it also represents potential dilution for existing shareholders.
Positives
- The granting of stock options to a director aligns their interests with those of the shareholders.
- The vesting schedule incentivizes continued service and contribution to the company over time.
Industry Context
Stock options are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with shareholders and incentivizing company growth.
Stakeholder Impact
- Shareholders may experience potential dilution due to the issuance of new stock options.
- The granting of options incentivizes the director to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 03/25/2024 | 25,000 stock options were issued to the Reporting person that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $1.16 each |
| 06/18/2024 | Date of the earliest transaction and grant date of 50,000 stock options with an exercise price of $0.71. |
| 06/18/2024 | First tranche of the 50,000 stock options vests. |
| 12/18/2024 | Second tranche of the 50,000 stock options vests. |
| 06/18/2025 | Final tranche of the 50,000 stock options vests. |
| 06/18/2034 | Expiration date of the 50,000 stock options. |
| 06/21/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.